The Diplomat
The Spanish Executive has resold to the Government of Andorra a total of 30,000 doses of Pfizer and BioNTech’s vaccine against Covid-19, as established in a resolution of the Spanish Agency of the Medicine published yesterday in the Official Bulletin of the State and which includes the agreement signed by the Ministry of Health with the Andorran Ministry of Health.
In his Twitter account, the Minister of Health, Salvador Illa, points out that it is “an exercise of responsibility and solidarity obliged by the impossibility of small countries to sign a contract with the pharmaceutical companies”.
The BOE details that in the context of the negotiations carried out by the European Commission to acquire vaccines, the need for some countries in our environment to benefit from access to vaccines that would guarantee these contracts was included.
Among the countries that were considered to be able to benefit in the first instance from this effort were the countries of the European Economic Area (EEA, Norway, Iceland and Liechtenstein) and the small countries located in the heart of the European Union (Andorra, Monaco, San Marino and Vatican City) that depend entirely on the supply chain of neighboring countries for the provision of medicines.
In the case of the Principality of Andorra, it was agreed that Spain would provide part of the allocated doses of Pfizer and BioNTech vaccines under the terms set out in the advance purchase agreement.
